bcbs semaglutide coverage Blue Cross Blue Shield Drops of GLP-1 Obesity Drugs Does Blue Cross Blue Shield

The stronger correlation between changes in waist circumference and body weight in the semaglutide group compared with placebo suggests that weight loss induced by semaglutide preferentially targets visceral adipositybut this still accounts for only a minority of the cardiovascular protection

There are no brand name medicines that lower total medical cost over a population, and generally health economists believe that drugs that cost less than $100,000 or $150,000 per QALY are high value. Implications for employers: The net cost of GLP-1 drugs is already just 42% of the list price, so a 50% list price cut might not lead to employer savings

10.1016/j.eprac.2023.02.001 [DOI] [PubMed] [Google Scholar] 63.Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al

( a ) Quantification of viral expression of the PDE4-cat virus represented as percentage of either AP or NTS (Ex1: example 1, Ex2: example 2)